Abstract ISI
ANNALS OF ONCOLOGY  (2010)

SAFETY AND EFFICACY RESULTS FROM A PHASE 1/2 STUDY OF THE ANTI-IGF-IR ANTIBODY FIGITUMUMAB IN PATIENTS WITH REFRACTORY EWING'S AND OTHER SARCOMAS

Juergens, H; Daw, NC; Oberlin, O; Ferrari, S; Villarroel M.; Doz, F; Whelan JS; Wang, T; Paccagnella, L